KYOTO -- A team of Japanese doctors last week performed landmark surgery that transplanted stocked, donated induced pluripotent stem, or iPS cells, into a patient with an intractable eye disease.
If successful, the surgery at Kobe City Medical Center General Hospital, performed under a joint project also involving researchers from Riken and Kyoto University's Center for iPS Cell Research and Application, or CiRA, will pave the way for wider use of regenerative treatment.
